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Abstract 
Background:  Workplace inhalational exposures to low molecular weight (LMW) chemicals cause 
hypersensitivity pneumonitis (HP) as well as the more common manifestation of respiratory 
hypersensitivity, occupational asthma (OA). 
 
Aims: To explore whether chemical causation of HP is associated with different structural and 
physico-chemical determinants from OA.     
 
Methods:  Chemical causes of human cases of HP and OA were identified from searches of peer-
reviewed literature up to the end of 2011.  Each chemical was categorised according to whether or 
not it had been the attributed cause of at least one case of HP.  The predicted asthma hazard was 
determined for each chemical using a previously developed quantitative structure-activity 
relationship (QSAR) model.  The chemicals in both sets were independently and ‘blindly’ analysed by 
an expert in mechanistic chemistry for a qualitative prediction of protein cross-linking potential and 
determination of lipophilicity (log Kow). 
 
Results:  Ten HP causing chemicals were identified and had a higher  median QSAR predicted asthma 
hazard than the control group of 101 OA causing chemicals (p < 0.005).  Nine of ten HP causing 
chemicals were predicted to be protein cross-linkers compared to 24/92 controls (p<0.0001).  The 
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distributions of log Kow indicated higher values for the HP list (median 3.47)  compared to controls 
(median 0.81) (p < 0.05). 
 
Conclusion: These findings suggest that chemicals capable of causing HP tend to have higher 
predicted asthma hazard, are more lipophilic and are more likely to be protein cross-linkers than 
those causing OA. 
 
Key words: hypersensitivity pneumonitis, occupational chemicals, occupational respiratory disease, 
toxic inhalation 
 
 
Key points: 
1. Only a relatively small number of reported cases of occupational hypersensitivity pneumonitis 
(HP)  have been attributed to low molecular weight (LMW)  chemicals - as opposed to high molecular 
weight agents causing HP, or LMW chemicals causing occupational asthma (OA). 
2. Quantitative and qualitative approaches to structure-activity relationships offer a valuable means 
of exploring mechanistic differences between HP and OA when caused by LMW chemicals. 
3. Preliminary results suggest that the ability of a chemical respiratory sensitiser to cause HP is 
associated with lipophilic and protein cross-linking properties.
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Introduction 
Reports of hypersensitivity pneumonitis (HP) with causal attribution to a chemical of low molecular 
weight (LMW) show potential for significant respiratory distress [1].  However, as has been described 
in the context of occupational asthma (OA) due to hypersensitivity [2,3,4],  detailed study of the 
chemical features characteristic of LMW causes of HP might reveal important insights into disease 
mechanisms and perhaps lead to a model for predicting chemicals with the potential to cause HP. 
This paper is the first to report as a pilot the possible application of Structure Activity Relationship  
models in predicting or explaining occupational HP hazard. 
 
A validated quantitative structure-activity relationship (QSAR) model had been developed by a 
statistical comparison of the molecular descriptors present in chemicals reported to cause OA in 
humans with those in control chemicals (for which no case reports of asthma had been reported 
despite extensive human industrial exposure) [5,6].  One of the important structural features found 
to be statistically associated with chemical asthmagenicity was the presence of two or more reactive 
or functional groups in a molecule [7,8,9].  A possible reason why such polyfunctionality might be 
necessary for a chemical to be asthmagenic could be that it confers the potential to cross-link native 
human proteins, perhaps leading to conformational change and the exposure of epitopes capable of 
provoking an immune reaction that leads to asthma. Alternatively cross-linking might operate at a 
cell surface level.  Cross-linking of protein molecules by a polyfunctional chemical has also been 
suggested by experts in mechanistic chemistry to confer electrochemical stability for protein binding 
that might not be achieved by reaction of a single chemical group alone [10,11].  A preliminary 
literature search for chemical causes of HP had identified two compounds, toluene tri-isocyanate 
[12] and pyromellitic di-anhydride [13], that exhibit a greater degree of  polyfunctionality than the 
more commonly reported  asthmagenic compounds in the same groups (a range of di-isocyanates 
and mono-anhydrides).  
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The pathology of OA and HP differs in the anatomical site with OA resulting from inflammation of 
the distal bronchi and bronchioles whilst HP, as indicated by its alternative name “(extrinsic) allergic 
alveolitis”, predominantly affects the alveoli.   It is therefore also plausible that HP causing chemicals 
differ from OA causing chemicals in toxicokinetic  properties such as relative solubility in water and 
lipid, given that lipophilic compounds would be more likely to partition at the level of the alveoli 
than at a bronchial level and that its molecules would need to cross a lipid rich surfactant layer in 
order to cause HP [14].  The objectives of this study were therefore to investigate the following 
hypotheses: 
1. To investigate the application of a QSAR designed for predicting chemicals capable of causing 
occupational asthma to the prediction of HP causing chemicals.    
2. To compare chemical structural and physico-chemical properties of occupational asthmagens and 
occupational causes of HP with particular reference to protein cross-linking potential and 
lipophilicity. 
 
Methods 
A literature search was undertaken  to generate as comprehensive lists as possible of LMW 
chemicals reported to cause at least one human case of HP (the ‘HP list’) and those reported to 
cause at least one human case of occupational asthma  due to sensitisation but no cases of HP (the 
‘OA list’).  For a chemical reported as the aetiological agent in either a case of OA or HP to be 
included in either list it had to be both organic (defined as carbon containing) and of molecular 
weight less than 1000 Da.    
 
The process of literature searching began with the iteration and expansion of an already existing 
database of OA causing chemicals [5].  The Medline database was searched for journal articles 
published up to the end of 2011, which potentially contained case reports or series of OA caused by 
a LMW chemical.   Search terms used either individually or in combination for Keyword, Topic and 
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Textword based searches included   ‘asthma’, ‘occupational asthma’, ‘respiratory sensitis(z)ation’, 
‘respiratory sensitis(z)er’, ‘chemical’, ‘low molecular weight’.  Articles that described either a case or 
case series of OA caused by a LMW organic compound were selected by scrutinising the title, 
abstract and where indicated the full article as described previously [5].  The criteria for OA diagnosis 
and causal attribution to a specific chemical were also the same as those previously used [5] in that 
the case report or series had to describe at least one clear diagnosis of OA attributed to a specific 
LMW organic compound following a latent period of exposure.    
 
The same database, time frame and search strategy was employed to identify cases of HP with 
causal attribution to a LMW organic chemical.  A different set of search terms was used which 
included the following either individually or in combination: ‘pneumonitis’, ‘alveolitis’, 
‘hypersensitivity pneumonitis’, ‘allergic alveolitis’, ‘respiratory sensitis(z)er’, ‘chemical’, ‘low 
molecular weight’.  A second stage involved combining search results using each chemical name 
from the provisional OA list and ‘hypersensitivity pneumonitis’ or synonyms.  From these search 
results the title, abstract and where indicated the full article were scrutinised in order to select all 
possible case reports or series describing HP with causal attribution to a LMW chemical.  The search 
terms ‘pneumonitis’ and ‘alveolitis’ were employed without the respective pathophysiological 
descriptors ‘hypersensitivity’ and ‘allergic’ in order to try to screen for as many case reports of  HP 
as possible.   Care was then taken in the final selection to ensure that the case report or series 
definitely described pneumonitis resulting from hypersensitivity rather than a non-immunological 
type of chemical pneumonitis such as lipoid pneumonitis.   Chemicals were therefore only included 
in the HP list if either the case report(s) clearly specified and discussed hypersensitivity mechanisms 
and there had been a latent period of exposure to the attributed cause.   
 
When a given chemical had been reported to cause both HP and OA either within the same case or 
as individual conditions in separate cases the chemical was included in the HP list rather than the OA 
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list.  The reasoning for this was that the number of chemicals reported to cause HP was predicted to 
be small by comparison with the number that cause OA and the study was aiming to examine the 
chemical features that differentiated this small subset of HP causing chemical respiratory sensitisers 
that overlapped with the larger subset of OA causing chemical respiratory sensitisers.  A compound 
was only included in either list if the name used in the case report(s) or series gave it unambiguous 
identity. 
 
For each compound in either the HP or OA list further information pertaining to CAS Registry 
Number and chemical structure were obtained from either The Merck Index [15] or one of several 
web based databases freely available online:  
1. The ChemExper Chemical Directory . Available from: http://www.Chemexper.com 
2. NCBI. PubChem.  Available from: http://pubchem.ncbi.nlm.nih.gov/ 
3. Chemical Book . Available from: http://www.chemicalbook.com 
4. Royal Society of Chemistry. ChemSpider. Available from: http://www.chemspider.com/    
 
Using one of these online databases it was usually possible to download the structure of each 
compound in the form of a ‘molfile’, which is an alphanumeric textual representation of a chemical 
structure.   When a molfile was not available online for a compound the structure was drawn using 
ChemDraw software which allows conversion into a molfile format.  The molfile for each compound 
was then opened in text form using Notepad and cut and pasted into the box indicated on the 
Occupational asthma hazard prediction programme’s webpage: 
http://www.coeh.man.ac.uk/asthma/login.php 
 
On submission of a chemical’s molfile this programme generates a value, known as the ‘asthma 
hazard index’ (HI),  between zero and one representing the determined probability that the given 
compound has potential to cause asthma by sensitisation. 
7 
 
 
The qualitative prediction of whether or not a given compound in the HP or OA lists has the potential 
to cross-link proteins was performed by an expert chemist [SJE] working independently.  In order to 
ensure that for this categorisation the independent investigator was blind to whether a given 
compound was on the OA list or HP list these lists were pooled and then listed in alphabetical order 
alongside the identified CAS Registry Number before being sent to the expert chemist.  
 
The expert chemist independently sought the chemical structure for each compound on the pooled 
HP/OA list using the Royal Society of Chemistry database, ChemSpider.  Each compound for which a 
structure was so identified was categorised as either a potential protein cross-linker or not based on 
whether or not, in the expert chemist’s opinion, it had at least two structural groups with the 
potential to react with amino acid side chains on endogenous proteins.  
 
The logarithm of the coefficient of partition between octanol and water (log Kow) was used to 
ascribe a value for lipophilicity to each compound for which a structure was identified by the expert 
chemist.  (The interpretation is that the larger the value of log Kow for a chemical, the more 
lipophilic i.e. fat soluble and the less hydrophilic i.e. water soluble it will be) The chosen method for 
determining this parameter for each compound utilised publicly available computer software known 
as KOWWIN, developed by the US Environmental Protection Agency [16]. It allows the 
determination of log Kow values for any chemical structure utilising an atom/fragment contribution 
method. Briefly, the approach breaks a molecule into a series of predefined chemical 
atoms/fragments, each atom/fragment has a defined logKow value determined from an analysis of 
experimental data. This allows simple QSAR models to be used to predict the logKow value of the 
entire chemical by counting the number of atoms/fragments and summing their contributions. 
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Statistical comparisons between the chemicals in the HP list and those in the OA list were performed 
for each of the three study parameters; QSAR generated asthma hazard index, cross-linking potential 
and log Kow.   The Mann-Whitney U test was used where the variable was continuous but not 
thought to have a normal distribution as was the case for QSAR generated asthma hazard index and 
log Kow.  Pearson Chi-square test was used to compare the chemicals on the HP and OA lists where 
the variable being compared was categorical as was the case for protein cross-linking potential.  All 
statistical analysis was done using SPSS version 20.  
 
Ethical approval was not required for this study as the only data used was existing human and 
toxicological data that were already in the public domain. 
 
 
Results 
The literature search identified 101 compounds which met the criteria for inclusion in the OA list 
(supplementary table 1) and 10 compounds which met the criteria for inclusion in the HP list (table 
1). Nine of the 10 chemicals on the HP list had also been reported to cause OA due to sensitisation 
either coexisting with HP or as the sole manifestation of hypersensitivity. 
 
It was possible to generate a HI using the QSAR for all 101 compounds on the OA list (supplementary 
table 1) and all compounds on the HP list (table 1).  The median HI value for the 101 control 
chemicals (‘the OA list’) was 0.92  (interquartile range  0.48 to 1).  The upper and lower quartile HI 
values of the 10 HP causing chemicals had values of 1 and the variation of HI across this set of 
chemicals differed significantly from that of the control set; p < 0.005 using the Independent 
Samples Mann-Whitney U test (figure 1). 
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The expert chemist working independently, and therefore using independent search strategies to 
identify chemical structures, was able to identify unambiguous structures for all ten of the 
compounds on the HP list but only 92 of the 101 controls on the OA list.   
 
Nine of the ten chemicals identified as having caused HP were predicted to be cross-linkers by the 
expert in mechanistic chemistry [SJE].   The proportion of predicted cross-linkers differed 
significantly from that in the control set which was 24 out of 92 (25%); p < 0.0001 using Pearson Chi-
square test  (table 2).   
 
The median log Kow value for the 92 control chemicals was 0.81 (interquartile rang -0.34 to 2.88). 
The median log Kow value for the 10 HP causing chemicals was 3.47 (interquartile range 0.86 to 
4.80) and the variation across this group differed significantly from the variation in log Kow across 
the set of 92 controls; p < 0.05 using the Independent Samples Mann-Whitney U test (figure 2). 
 
Discussion 
This study set out to explore whether low molecular weight organic compounds that have been 
reported to cause hypersensitivity pneumonitis (HP) have structural features or physico-chemical 
properties that distinguish them from occupational asthma (OA) causing chemical respiratory 
sensitisers that do not cause HP.  Despite the relatively low number of chemicals reported to cause 
HP the study results indicate, with statistical significance, that HP causing chemicals tend to have a 
stronger QSAR predicted asthma hazard, are more lipophilic and have greater potential for protein 
cross-linking than those causing OA.   
 
The small size of the set of LMW chemicals identified as causative of HP from peer reviewed case 
reports was expected.  HP is a much rarer condition than OA and LMW chemicals are much less 
frequently reported as causative agents than are high molecular weight substances containing 
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antigenic proteins e.g. ‘Farmer’s lung’ caused by mouldy hay.  Chemical causes tend to be briefly 
alluded to at the bottom of lists of aetiological agents in review articles of HP in categories such as 
‘Chemical worker’s lung’ attributed to limited and generalised chemical groups such as diisocyanates 
and acid anhydrides [24].  We have identified ten specific LMW organic compounds reported to have 
caused HP in humans.   The report of a diagnosis of hypersensitivity pneumonitis (or allergic 
alveolitis) and causal attribution to a LMW chemical by a physician in a peer reviewed journal was 
considered sufficient evidence that the diagnostic criteria had been met for HP.  A latent period of 
exposure was, however, deemed a necessary criterion to exclude causes of lipoid pneumonia since 
the study was limited to HP and not all causes of chemical pneumonitis (especially since lipophilicity 
was a property being tested in relation to possible association with HP).    
 
The final list of HP causing chemicals that is shown in table 1 includes several specific diisocyanates, 
all of which are also well recognised causes of OA.  Amongst the acid anhydrides, however, our 
literature search found sufficient evidence of causation of HP for only pyromellitic dianhydride.   The 
evidence for HP causation by any of the acid anhydrides which are more usually associated with 
asthma is not conclusive.  There are two published case reports of HP associated with polyester 
powder paint [25,26].  Piirila et al [25] made an assumption that the HP causing agents in their case 
were acid anhydrides present in the paint fumes in which they  detected small concentrations of 
these chemicals by gas chromatography.   Cartier et al [26], however, left the possibility open that 
the alveolitic reaction in their case was due to linear saturated polyesters or released LMW 
compounds such as aldehydes.  They excluded trimellitic anhydride as the cause by performing a 
specific inhalation challenge  test which was negative.  Neither of these case reports were therefore 
considered as sufficient evidence in this study that either phthalic anhydride or trimellitic anhydride 
are causes of HP. 
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Pyromellitic dianhydride was the only chemical identified as a reported cause of HP that has 
apparently never been reported to cause OA.  All the remaining compounds listed in table 1 have 
either been reported to cause OA as the sole pathology in other cases or, as with triphenylmethane 
triisocyanate, coexisting in a single case of HP.  Interestingly our control group of 101 asthma causing 
chemical respiratory sensitisers had a lower mean QSAR generated asthma hazard index than the 10 
HP causing chemicals.  This could be a manifestation of the high representation of diisocyanates 
which account for 50% of the HP causing chemicals identified.   Another possible explanation of this 
finding is that the molecular descriptors associated with asthmagenicity are even more frequent in 
molecules of HP causing chemicals, perhaps indicative of the requirements for protein reactivity that 
lead to subsequent immunopathological events.   Asthma, when caused by LMW chemicals, 
sometimes results from IgE-mediated type I hypersensitivity but also by as yet poorly characterised 
immunological or other mechanisms.  By contrast HP, at least when caused by HMW agents, is 
thought to result from type III and type IV hypersensitivity mechanisms and IgG antibodies 
interacting with complement components to trigger the cellular accumulation of macrophages and 
T-lymphocytes. 
 
The hypothesis that cross-linking of native human proteins is an initial step in chemical 
asthmagenesis was developed from observations that two or more reactive groups were frequently 
present in chemical respiratory sensitisers that caused asthma [3].  A chemical respiratory sensitiser 
is not a complete antigen and is thought to be antigenic by reaction with native human proteins.  A 
single bond with a native protein molecule can produce a hapten-protein conjugate that can 
function as an epitope that might be responsible for initiating asthma or rhinitis for some chemical 
respiratory sensitisers. This process is, however, unlikely to be a sufficient trigger for the 
immunological processes involved in HP which involve immune complex formation.  An immune 
complex could, however, be formed if a chemical forms intramolecular and/or intermolecular cross-
links in protein molecules.  The formation of intramolecular protein cross-links could expose multiple 
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self epitopes leading to polyclonal (auto)antibody (IgG) production.  Bivalent IgG could then cross-
link one protein molecule with another commencing the formation of an immune complex lattice. 
This would be essentially the same process as that triggered by a HMW antigen, e.g. fungal antigens 
in mouldy hay, except that the postulated antigen is a self protein made autoantigenic by 
conformational change from crosslinking by the chemical sensitiser.   
 
The exception to this hypothesis is Pauli’s reagent (4-diazobenzenesulphonate) for which there was 
strong clinical evidence of correct causal attribution, including positive specific inhalation challenge 
and histopathological features of pneumonitis found following lung biopsy.  The case was unusual, 
however, in that specific IgE was demonstrated by skin prick testing as well as histological findings of 
immunoglobulin deposition in alveoli and low serum C3.  Interestingly specific inhalation challenge 
resulted in both immediate and late bronchial responses and this could be a case in which a chemical 
respiratory sensitiser was acting via IgE-mediated mechanisms to cause asthma and other 
mechanisms to cause pneumonitis which may or may not be immunologically mediated.   
 
The case report of HP caused by pyromellitic acid dianhydride  included detailed immunoserological 
analysis which suggested that serum IgG in the patient exposed to pyromellitic acid dianhydride at 
work had been cross-linked to form dimers.  Further examples of such in vivo evidence together with 
in vitro studies would be required to prove that cross-linking of human proteins by a chemical 
respiratory sensitiser is necessary to generate the antigenic trigger for the immunopathology of HP.  
The initial chemical reactions are easy to illustrate mechanistically (figure 3). 
 
There is a biologically plausible explanation for lipophilicity being an important requirement for 
chemicals to cause HP.  Type II alveolar cells produce a lipoprotein surfactant layer in order to 
reduce surface tension of expanding alveoli.  It comprises phospholipids such as 
dipalmitoylphosphatidylcholine which has two hydrophobic tails projecting into the air facing side of 
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this surfactant layer which is strongly hydrophobic [27].  In order to partition in this layer and enter  
the alveolar interstitium a chemical would need to be lipophilic [14].  This concept is clearly evident 
in lipoid pneumonia, a form of chemical pneumonitis in which the pathological mechanism does not 
involve immunologic hypersensitivity but results from the acute inhalation of certain oil based 
substances [28].  Lipophilicity, in conjunction with any structural features necessary to confer the 
required toxicodynamic properties might also be a requirement in the development of chemical 
induced HP. 
 
The development of a QSAR prediction model for HP analogous to that for asthma [5] is a worthy 
long term aim. However, as this paper shows the dataset available so far is too limited.   There are 
also only infrequent case reports with which to explore the mechanistic hypotheses.  Some agents 
such as clozapine [29] have been reported as causing pneumonitis but not through hypersensitivity 
mechanisms.  Indeed clozapine is a lipophilic compound (log Kow 3.35) and it scores highly on the 
asthma QSAR (HI 0.93).  For some LMW agents that cause pneumonitis hypersensitivity mechanisms 
are clearly involved but the specific causative chemical entity has not been identified.  An example is 
pyrethrum [30] which comprises two pyrethrin compounds both of which are lipophilic (figure 4).  
Application of the hypotheses presented here might lead to speculation that pyrethrin II is the 
specific HP causing compound  because it has two electrophilic centres giving it potential for protein 
cross-linking, whereas pyrethrin I only appears to have one such centre that could bond with a 
protein side chain.  
 
The pilot study reported here has generated plausible hypotheses that lipophilicity and protein 
cross-linking properties are important requirements for a chemical to be capable of causing 
hypersensitivity pneumonitis.  Corroboration of these suggested disease mechanisms would 
probably require both laboratory investigation and clinico-epidemiologic studies. 
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Table 1. LMW chemicals reported to cause HP in peer-reviewed literature with their structures and study parameters 
Chemical Name 
[example case reference] 
CAS Registry 
Number 
Chemical structure 
Ever reported to 
cause OA? Y/N 
QSAR generated 
Hazard Index 
(0-1) 
Cross-linking 
potential Y/N 
Log 
Kow 
1,3-Bis(isocyanatomethyl)cyclohexane 
 
[17] 
38661-72-2 
N
N
O
O  
Y 1 Y 3.92 
1,5-Naphthalene diisocyanate 
[1] 
3173-72-6 
N
N
O
O  
Y 1 Y 4.37 
Diphenylmethane diisocyanate 
 
[18] 
101-68-8 NN
O
O  
 1 Y 5.22 
Formaldehyde 
 
[19] 
50-00-0 
O  
 1 Y 0.35 
Hexamethylene diisocyanate 
 
[20] 
822-06-0 N
N
O
O  
Y 1 Y 3.2 
4-diazobenzenesulphonate 
 (Pauli’s reagent) 
 
[21] 
305-80-6 
S
N
+
O
N
O
O
 
Y 
(Only in conjunction 
with HP) 
0.31 N -0.8 
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Pyromellitic dianhydride 
 
[11] 
89-32-7 
O
O
O
O
O
O  
N 1 Y 2.14 
Toluene diisocyanate 
 
[22]  
584-84-9 
N
N
O
O
 
Y 1 Y 3.74 
Triglycidyl isocyanurate 
 
[23] 
 
2451-62-9 
N
N
N
O
O
O
O
O
O
 
Y 1 Y 1.21 
Triphenylmethane triisocyanate 
 
[10] 
2422-91-5 
N
N
O
O
N
O
 
Y 
(Only in conjunction 
with HP) 
1 Y 7.17 
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Table 2. Proportions of respiratory sensitisers (RS) predicted to be protein cross-linkers 
 
Numbers of chemical 
RS reported to cause 
HP 
Numbers of chemical 
RS reported to cause 
OA but not HP 
Total 
Predicted to have 
cross-linking 
potential 
9 24 33 
Predicted not to 
have cross-linking 
potential 
1 68 69 
Total 10 92 102 
p < 0.0001  (Pearson chi-square test)  
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Figure 3. Reaction of a pyromellitic dianhydride molecule  with two lysine side chains of either the 
same protein (causing intramolecular cross-linking) or different proteins (causing intermolecular 
cross-linking) 
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Pyrethrin I Pyrethrin II  
 
 
Figure 4.  Core structure of pyrethrins (arrows indicate potential sites of nucleophilic attack by 
nitrogen containing lysine residues) 
 
 
 
 
 
 
 
 
Pyrethrin I    (CAS RN 121-21-1)    log Kow = 6.28 HI = 0.89 
Pyrethrin II   (CAS RN 121-29-9)    log Kow = 5.33 HI = 0.99 
 
